Affiliation:
1. Department of Radiation Oncology; Massachusetts General Hospital and Harvard Medical School; Boston MA USA
2. Department of Radiation Oncology; Miami Cancer Institute; Miami FL USA
Funder
Massachusetts General Hospital
Proton Therapy Research and Treatment Center
Prostate Cancer Foundation
Reference37 articles.
1. Rationale, conduct, and outcome using hypofractionated radiotherapy in prostate cancer;Ritter;Semin Radiat Oncol,2008
2. Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) Gy;Miralbell;Int J Radiat Oncol Biol Phys,2012
3. Is the α/β value for prostate tumours low enough to be safely used in clinical trials?;Daşu;Clin Oncol,2007
4. Hypofractionated radiotherapy for prostate cancer;Hegemann;Radiat Oncol,2014
5. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial;Dearnaley;Lancet Oncol,2016
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献